In a joint live stream on Elawady's channel, a speaker (Elawady or his guest Dr. Tamer El-Baz; speaker turns cannot be identified) describes a coeliac patient on the system who reintroduced gluten-containing toast, and advises pausing it when symptoms appear and reintroducing it later.
Original statement
ارتاح اتحس فبدا يدخل التوست يعني انا عندي عينه ا سيليك ... اول ما خدت التوست تعبت شويه ... طب استنى وقفيه شويه خلينا نمشي على النظام ورجعيه تاني
verbatim according to source. Translation by the project; the Arabic wording is authoritative.
Translation
In a joint live stream on Elawady's channel, a speaker (Elawady or his guest Dr. Tamer El-Baz; speaker turns cannot be identified) describes a coeliac patient on the system who reintroduced gluten-containing toast, and advises pausing it when symptoms appear and reintroducing it later.
Origin
- Source status
- Video transcript (own words)
- Attribution
- Elawady or guest (machine transcript of a joint live stream; speaker not identifiable)
- Video
- لايف الدكتور تامر الباز ❤️❤️❤️❤️ (Open source)
- Published
- 18 July 2025
- Timestamp
- not available (transcript has no timings)
- Attribution uncertainty
- Machine transcript of a live stream with Dr. Tamer El-Baz (two speakers separated by '>>'); it cannot be determined which statements are Elawady's. Treat as statements made on Elawady's channel with uncertain speaker.
- Claimed mechanism
Coeliac symptoms are due to other foods (eggs etc.), not gluten.
- Claimed health effect
Coeliac patients improve and tolerate toast.
- Population concerned
People with coeliac disease.
- Geographic restriction by Elawady
none found
Scientific assessment
False – The statement contradicts the robust evidence.
Certainty of evidence: high – Further research is very unlikely to change the assessment.
1. What was claimed?
Coeliac patients on the system can eat toast again.
2. What is demonstrably correct?
Some people with a coeliac label may have been misdiagnosed; re-evaluation by a gastroenterologist is legitimate.
3. What is wrong or exaggerated?
For confirmed coeliac disease, gluten reintroduction is harmful, regardless of symptoms; symptom improvement after removing other foods does not prove gluten tolerance.
4. What remains unclear?
Speaker attribution.
5. Which studies support it?
None.
6. Which studies contradict it?
7. What applies to Germany and Europe?
ESsCD: lifelong gluten-free diet with follow-up serology.
8. What is known about Egypt?
Same medical standard.
9. What practical conclusion is appropriate?
Coeliac patients should not reintroduce gluten outside a supervised diagnostic re-evaluation.
Assessment details
- Rationale for certainty of evidence
The treatment of coeliac disease is a strict gluten-free diet (I-GRN-02); reintroducing gluten causes ongoing intestinal damage even when symptoms are mild. Anecdotal symptom improvement does not show mucosal healing.
- Source quality
Anecdote in a conversation; speaker attribution uncertain.
- Regional transferability
Universal.
- Individual exceptions
None.
- Regional scope of the claim
- general (biological/medical)
- Last reviewed
- 25 October 2026 provisional
In plain language
In a live conversation on the channel, coeliac patients were described as reintroducing toast after following the system. For people with confirmed coeliac disease, gluten keeps damaging the gut even if they feel only a little unwell. The accepted treatment is a strict gluten-free diet for life. Any doubt about the diagnosis should be checked by a specialist.
Studies on this claim
Studies supporting the claim (0)
No studies in this group.
Studies contradicting or limiting the claim (2)
-
European guideline for coeliac disease
Al-Toma A et al.. United European Gastroenterol J 2019 · PMID 31210940 · DOI 10.1177/2050640619844125Guideline / position statementindependent cross-checkfull text checked★ key studyCoeliac disease needs a strict lifelong gluten-free diet; gluten is in wheat, rye and barley (not in uncontaminated rice, maize or oats); non-coeliac gluten sensitivity is recognised after coeliac disease and wheat allergy are excluded.
Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Guideline
- How was the study done?
Expert consensus guideline with GRADE grading, based on a PubMed literature review
- What was actually found?
GFD is treatment
- What do the results mean in everyday life?
Coeliac patients must avoid gluten
- What are the study's limitations?
Not based on a systematic review; small expert board; no conflict-of-interest statement in available text
- What does it say about Elawady's specific claim?
Contradicts denial and reintroduction claims
- Do the results apply to Germany and Europe?
High
- What can explicitly not be concluded from this study?
Does not quantify how common NCGS is or whether gluten itself (rather than fructans/ATIs) causes its symptoms
-
How common is coeliac disease?
Singh P et al.. Clin Gastroenterol Hepatol 2018 · PMID 29551598 · DOI 10.1016/j.cgh.2017.06.037Meta-analysisindependent cross-checkabstract only checked★ key studyAbout 1 in 70 have coeliac antibodies and about 1 in 140 biopsy-confirmed disease worldwide.
Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Prevalence
- How was the study done?
Meta-analysis
- How many people, animals or samples were studied?
96 studies
- What was actually found?
0.7-1.4%
- What do the results mean in everyday life?
Coeliac disease is real and not rare
- What are the study's limitations?
Heterogeneity
- What does it say about Elawady's specific claim?
Contradicts denial of gluten disease
- Do the results apply to Germany and Europe?
High
- What can explicitly not be concluded from this study?
Causes of symptoms in non-coeliacs
No study in this group is marked as key.
Studies with mixed or unclear results (0)
No studies in this group.
Regional context
Germany / EU
ESsCD: lifelong gluten-free diet with follow-up serology.
Egypt
Same medical standard.
What applies in my country?
General scientific assessment
False Reintroducing gluten in coeliac disease is unsafe.
The following areas of food safety are relevant to this statement:
- Pesticides and pesticide residues
- Mycotoxins (mould toxins)
Cereals and rice
Choose a country to see the checked information for it.
Limits: legal rules describe what is allowed, not what every single food contains. Measurement data come from samples and are meaningful only together with their method details.
Country of residence or purchase Compare with another country
References
- European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders.. Al-Toma A et al.. United European Gastroenterol J 2019 · PMID 31210940 · DOI 10.1177/2050640619844125
- Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis.. Singh P et al.. Clin Gastroenterol Hepatol 2018 · PMID 29551598 · DOI 10.1016/j.cgh.2017.06.037